Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China
- PMID: 24886028
- PMCID: PMC4229937
- DOI: 10.1186/1471-2334-14-260
Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China
Abstract
Background: Shigellae have become increasingly resistant to the extended-spectrum cephalosporin (ESC) worldwide and pose a great challenge to anti-infection treatment options. The purpose of this study was to determine the resistance, cephalosporin resistance mechanisms, virulence characteristic and genotype of ESC-resistant Shigella.
Methods: From 2008 to 2012, Shigella isolates collected from diarrhea patients were detected for antibiotics sensitivity by disk diffusion, cephalosporin resistance determinants and virulence genes using polymerase chain reaction (PCR) and genotyping through enterobacterial repetitive intergenic consensus sequence PCR (ERIC-PCR).
Results: A total of 356 Shigella isolates were gathered, and 198 (55.6%, 58 S. flexneri and 140 S. sonnei) were resistant to ESC. All ESC-resistant isolates were susceptible to imipenem, and only 0.5% isolate was resistant to piperacillin/tazobactam. ESC-resistant S. flexneri showed high degrees of resistance to ampicillin (100%), ampicillin/sulbactam (96.6%), piperacillin (100%), trimethoprim/sulfamethoxazole (74.1%), ciprofloxacin (74.1%), levofloxacin (53.4%), ceftazidime (58.6%) and cefepime (58.6%). ESC-resistant S. sonnei exhibited high resistance rates to ampicillin (100%), piperacillin (100%) and trimethoprim/sulfamethoxazole (96.4%). Cephalosporin resistance genes were confirmed in 184 ESC-resistant isolates. bla(CTX-M) types (91.8%, mainly bla(CTX-M-14), bla(CTX-M-15) and bla(CTX-M-57)) were most prevalent, followed by bla(OXA-30) (26.3%). Over 99.0% ESC-resistant isolates harbored virulence genes ial, ipaH, virA and sen. However, set1 were more prevalent in ESC-resistant S. flexneri isolates than in S. sonnei isolates. ERIC-PCR results showed that 2 and 3 main genotypes were detected in ESC-resistant S. flexneri and S. sonnei, respectively.
Conclusion: Our findings indicated that a high prevalence of ESC-resistant Shigella mediated mainly by bla(CTX-M) with stronger resistance and virulence, and the existence of specific clones responsible for these Shigella infection in the region studied.
Similar articles
-
Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India.J Antimicrob Chemother. 2012 Jun;67(6):1347-53. doi: 10.1093/jac/dks061. Epub 2012 Mar 12. J Antimicrob Chemother. 2012. PMID: 22410619
-
[Drug resistance and molecular epidemiology of Shigella isolated from children with diarrhea].Zhonghua Er Ke Za Zhi. 2012 Oct;50(10):777-81. Zhonghua Er Ke Za Zhi. 2012. PMID: 23302570 Chinese.
-
Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon.J Infect Dev Ctries. 2009 May 1;3(4):300-5. doi: 10.3855/jidc.128. J Infect Dev Ctries. 2009. PMID: 19759494
-
Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020.Emerg Infect Dis. 2022 Jun;28(6):1110-1116. doi: 10.3201/eid2806.220131. Emerg Infect Dis. 2022. PMID: 35608550 Free PMC article. Review.
-
Pathogenicity and virulence of Shigella sonnei: A highly drug-resistant pathogen of increasing prevalence.Virulence. 2023 Dec;14(1):2280838. doi: 10.1080/21505594.2023.2280838. Epub 2023 Nov 23. Virulence. 2023. PMID: 37994877 Free PMC article. Review.
Cited by
-
Low distribution of genes encoding virulence factors in Shigella flexneri serotypes 1b clinical isolates from eastern Chinese populations.Gut Pathog. 2017 Dec 16;9:76. doi: 10.1186/s13099-017-0222-9. eCollection 2017. Gut Pathog. 2017. PMID: 29270233 Free PMC article.
-
In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin.Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00086-17. doi: 10.1128/AAC.00086-17. Print 2017 Jul. Antimicrob Agents Chemother. 2017. PMID: 28483960 Free PMC article.
-
Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment.Infect Drug Resist. 2019 Oct 7;12:3137-3167. doi: 10.2147/IDR.S219755. eCollection 2019. Infect Drug Resist. 2019. PMID: 31632102 Free PMC article.
-
Epidemic and molecular characterization of fluoroquinolone-resistant Shigella dysenteriae 1 isolates from calves with diarrhea.BMC Microbiol. 2021 Jan 6;21(1):6. doi: 10.1186/s12866-020-02050-9. BMC Microbiol. 2021. PMID: 33407134 Free PMC article.
-
Shigella sonnei: virulence and antibiotic resistance.Arch Microbiol. 2021 Jan;203(1):45-58. doi: 10.1007/s00203-020-02034-3. Epub 2020 Sep 14. Arch Microbiol. 2021. PMID: 32929595 Free PMC article. Review.
References
-
- Kuo CY, Su LH, Perera J, Carlos C, Tan BH, Kumarasinghe G, So T, Van PH, Chongthaleong A, Song JH, Chiu CH. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001–2004. J Microbiol Immunol Infect. 2008;41:107–111. - PubMed
-
- Wang XY, Tao F, Xiao D, Lee H, Deen J, Gong J, Zhao Y, Zhou W, Li W, Shen B, Song Y, Ma J, Li ZM, Wang Z, Su PY, Chang N, Xu JH, Ouyang PY, von Seidlein L, Xu ZY, Clemens JD. Trend and disease burden of bacillary dysentery in China (1991–2000) Bull World Health Organ. 2006;84:561–568. doi: 10.2471/BLT.05.023853. - DOI - PMC - PubMed
-
- Ji WJ, Xu XW, Dong F. Genotype and drug resistance analysis of extended-spectrum beta-lactamases-producing Shigella in pediatric patients. Chin J Microbiol Immunol. 2010;30:472–476. (in Chinese) - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous